Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 7/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 5/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.48 |
| ▸ | CA1 | P00915 | 2/20 | 0.48 |
| ▸ | CA2 | P00918 | 2/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | CA7 | P43166 | 1/20 | 0.48 |
| ▸ | CA9 | Q16790 | 1/20 | 0.48 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.47 |
| ▸ | CES2 | O00748 | 1/20 | 0.42 |
| ▸ | CES1 | P23141 | 1/20 | 0.42 |
| ▸ | GSTP1 | P09211 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | RELA | Q04206 | 1/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11959837 | 0.92 | ALDH1A1 (0.50) | CYP2A6CYP1A2ALDH1A1CYP3A4HSD17B10 | |
| SCHEMBL14983311 | 0.92 | ALDH1A1 (0.50) | CYP2A6CYP1A2ALDH1A1CYP3A4HSD17B10 | |
| SCHEMBL12044703 | 0.90 | ESR1 (0.56) | CYP1A2ALDH1A1CYP3A4HSD17B10CA1 | |
| SCHEMBL19336401 | 0.90 | ESR1 (0.56) | CYP1A2ALDH1A1CYP3A4HSD17B10CA1 | |
| SCHEMBL14304431 | 0.87 | CYP2A6 (0.37) | CYP2A6CYP1A2ALDH1A1CYP3A4HSD17B10 | |
| SCHEMBL7925156 | 0.84 | CYP1A2 (0.40) | CYP2A6CYP1A2ESR1ESR2 | |
| SCHEMBL125090 | 0.81 | CYP2A6 (0.42) | CYP2A6CYP1A2ALDH1A1CYP3A4HSD17B10 | |
| SCHEMBL327596 | 0.79 | ALDH1A1 (0.61) | CYP2A6CYP1A2ALDH1A1HSD17B10TDP1 | |
| SCHEMBL13350161 | 0.79 | ESR1 (0.61) | CYP1A2ALDH1A1CYP3A4HSD17B10CA1 | |
| SCHEMBL14304380 | 0.78 | ESR1 (0.57) | CYP1A2ALDH1A1CYP3A4CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 126 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3735411-B1 | 1,3,4,5-TETRAHYDRO-2H-PYRIDO[4,3-B]INDOLE DERIVATIVES FOR THE TREATMENT, ALLEVIATION OR PREVENTION OF DISORDERS ASSOCIATED WITH TAU AGGREGATES LIKE ALZHEIMER`S DISEASE | AC IMMUNE SA (CH) | 2024-07-10 | — | — | EP | disclosed |
| EP-4276924-A1 | ORGANIC LIGHT EMITTING DEVICE | Lg Chem, Ltd. (KR) | 2023-11-15 | — | — | EP | disclosed |
| EP-4265619-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | LT Materials Co., Ltd. (KR) | 2023-10-25 | — | — | EP | disclosed |
| US-11793064-B2 | Organic metal complex, and organic light emitting device and display apparatus using the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2023-10-17 | — | — | US | disclosed |
| EP-4258372-A1 | ORGANIC LIGHT-EMITTING DEVICE | Lg Chem, Ltd. (KR) | 2023-10-11 | — | — | EP | disclosed |
| EP-4254527-A1 | ORGANIC LIGHT EMITTING DEVICE | Lg Chem, Ltd. (KR) | 2023-10-04 | — | — | EP | disclosed |
| WO-2023171951-A1 | ORGANIC LIGHT-EMITTING DEVICE, METHOD FOR MANUFACTURING SAME, AND COMPOSITION FOR ORGANIC MATERIAL LAYER | 엘티소재주식회사 | 2023-09-14 | — | — | WO | disclosed |
| EP-4243102-A1 | ORGANIC LIGHT-EMITTING DEVICE | Lg Chem, Ltd. (KR) | 2023-09-13 | — | — | EP | disclosed |
| CN-111635413-B | Compound, organic electronic device including the same, and display device or lighting device including the same | 苏州大学 | 2023-08-01 | — | — | CN | disclosed |
| WO-2023140529-A1 | ORGANIC ELECTRIC ELEMENT USING COMPOUND FOR ORGANIC ELECTRIC ELEMENT, AND ELECTRONIC DEVICE THEREOF | 덕산네오룩스 주식회사 | 2023-07-27 | — | — | WO | disclosed |
| US-20100076201-A1 | Carbazole Derivative and Method for Producing the Same | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2010-03-25 | — | — | US | disclosed |
| US-20090156849-A1 | Catalyst for Asymmetric Synthesis, Ligand for Use Therein, and Process for Producing Optically Active Compound through Asymmetric Synthesis Reaction Using Them | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2009-06-18 | — | — | US | disclosed |
| WO-2009066808-A1 | AROMATIC ELECTROLUMINESCENT COMPOUNDS WITH HIGH EFFICIENCY AND ELECTROLUMINESCENT DEVICE USING THE SAME | GRACEL DISPLAY INC. (KR) | 2009-05-28 | — | — | WO | disclosed |
| US-20090115323-A1 | OLIGOFLUORENE COMPOUND AND ORGANIC EL ELEMENT USING SAME | CANON KABUSHIKI KAISHA (JP) | 2009-05-07 | — | — | US | disclosed |
| US-7511104-B2 | Polyolefins made by catalyst comprising a noncoordinating anion and articles comprising them | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2009-03-31 | — | — | US | disclosed |
| WO-2008082178-A1 | DIARYL TRIANTHRACENE DERIVATIVES AND ORGANIC LIGHT EMITTING LAYER OR DIODE COMPRISING THE SAME | DOOSAN CORPORATION (KR) | 2008-07-10 | — | — | WO | disclosed |
| US-7297653-B2 | Fluorophenylborates and their use as activators in catalyst systems for olefin polymerization | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2007-11-20 | — | — | US | disclosed |
| US-7212284-B2 | Method for forming nanoparticle films and application thereof | GENERAL ELECTRIC COMPANY (US) | 2007-05-01 | — | — | US | disclosed |
| US-20070021575-A1 | Fluorophenylborates and their use as activators in catalyst systems for olefin polymerization | EXXONMOBIL CHEMICAL PATENTS INC. | 2007-01-25 | — | — | US | disclosed |
| WO-2004085408-A1 | 2, 3, 6-TRISUBSTITUTED-4-PYRIMIDONE DERIVATIVES | MITSUBISHI PHARMA CORPORATION (JP) | 2004-10-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090156849-A1 | Catalyst for Asymmetric Synthesis, Ligand for Use Therein, and Process for Producing Optically Active Compound through Asymmetric Synthesis Reaction Using Them | ME1, ATIC, ADH1A | CYP2A6 208/4885CYP1A2 433/4885ALDH1A1 12/4885 |
| US-20070021575-A1 | Fluorophenylborates and their use as activators in catalyst systems for olefin polymerization | ARF4, ARF1, ARFIP2 | CYP2A6 1684/4885CYP1A2 1675/4885ALDH1A1 3324/4885 |
| US-11793064-B2 | Organic metal complex, and organic light emitting device and display apparatus using the same | L1CAM, AP2M1, MRPL9 | CYP2A6 4002/4885CYP1A2 3715/4885ALDH1A1 2553/4885 |
| US-20090115323-A1 | OLIGOFLUORENE COMPOUND AND ORGANIC EL ELEMENT USING SAME | ELP1, LEF1, ELAVL1 | CYP2A6 2639/4885CYP1A2 1129/4885ALDH1A1 1040/4885 |
| US-20100076201-A1 | Carbazole Derivative and Method for Producing the Same | AADAC, CYP1A1, CYP1B1 | CYP2A6 83/4885CYP1A2 8/4885ALDH1A1 175/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.